Technical Analysis for GBIO - Generation Bio Co.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Lower Bollinger Band Walk | Weakness | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Down 5 Days in a Row | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
NR7 | Range Contraction | -2.88% | |
Narrow Range Bar | Range Contraction | -2.88% | |
Lower Bollinger Band Walk | Weakness | -2.88% |
Alert | Time |
---|---|
Rose Above Lower Bollinger Band | about 22 hours ago |
Down 1% | about 22 hours ago |
Possible NR7 | 1 day ago |
60 Minute Opening Range Breakdown | 2 days ago |
Down 3% | 2 days ago |
Get a Trading Sidekick!
- Earnings date: 11/07/2024
Generation Bio Co. Description
Generation Bio is an innovative genetic medicines company focused on creating a new class of gene therapy to provide durable, redosable treatments for patients suffering from both rare and prevalent diseases. The company’s non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company is designing therapies to provide targeted delivery of genetic payloads that include large and multiple genes across a broad array of tissues, and to be redosable for individualized and extended treatment throughout a patient’s life. The platform is designed to expand access to treatments for rare diseases and to address prevalent diseases through efficient, scalable manufacturing.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Emerging Technologies Rare Diseases Molecular Biology Gene Therapy Manufacturing Process Lipid Applied Genetics Gene Delivery
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 4.65 |
52 Week Low | 1.1 |
Average Volume | 129,194 |
200-Day Moving Average | 2.75 |
50-Day Moving Average | 2.29 |
20-Day Moving Average | 2.03 |
10-Day Moving Average | 1.81 |
Average True Range | 0.20 |
RSI (14) | 24.24 |
ADX | 30.99 |
+DI | 8.89 |
-DI | 36.45 |
Chandelier Exit (Long, 3 ATRs) | 1.97 |
Chandelier Exit (Short, 3 ATRs) | 1.89 |
Upper Bollinger Bands | 2.73 |
Lower Bollinger Band | 1.33 |
Percent B (%b) | 0.01 |
BandWidth | 68.61 |
MACD Line | -0.24 |
MACD Signal Line | -0.15 |
MACD Histogram | -0.0888 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.61 | ||||
Resistance 3 (R3) | 1.61 | 1.54 | 1.56 | ||
Resistance 2 (R2) | 1.54 | 1.47 | 1.53 | 1.55 | |
Resistance 1 (R1) | 1.44 | 1.43 | 1.41 | 1.44 | 1.53 |
Pivot Point | 1.37 | 1.37 | 1.35 | 1.36 | 1.37 |
Support 1 (S1) | 1.27 | 1.30 | 1.24 | 1.27 | 1.17 |
Support 2 (S2) | 1.20 | 1.26 | 1.19 | 1.15 | |
Support 3 (S3) | 1.10 | 1.20 | 1.14 | ||
Support 4 (S4) | 1.10 |